J. Lawson

Enhanced Sampling and Ligandability Assessment to Expand the Repertoire of Potentially Druggable Cryptic Pockets.

Certain proteins known to be involved in life-threatening diseases have remained challenging therapeutic targets for decades, simply because a suitable binding pocket for a potent molecular inhibitor could not be identified in their ground-state apo structures. In the past decade, the discovery of cryptic pockets in ch...